BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34739826)

  • 1. Catching mono- and poly-ADP-ribose readers with synthetic ADP-ribose baits.
    Cohen MS
    Mol Cell; 2021 Nov; 81(21):4351-4353. PubMed ID: 34739826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro.
    Lin KY; Huang D; Kraus WL
    Methods Mol Biol; 2018; 1813():91-108. PubMed ID: 30097863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADP-Ribosylation as Post-Translational Modification of Proteins: Use of Inhibitors in Cancer Control.
    Poltronieri P; Miwa M; Masutani M
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting Poly (ADP-Ribose) In Vitro and in Cells Using PAR Trackers.
    Challa S; Whitaker AL; Kraus WL
    Methods Mol Biol; 2023; 2609():75-90. PubMed ID: 36515830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SnapShot: ADP-Ribosylation Signaling.
    Hottiger MO
    Mol Cell; 2015 Jun; 58(6):1134-1134.e1. PubMed ID: 26091348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reading ADP-ribosylation signaling using chemical biology and interaction proteomics.
    Kliza KW; Liu Q; Roosenboom LWM; Jansen PWTC; Filippov DV; Vermeulen M
    Mol Cell; 2021 Nov; 81(21):4552-4567.e8. PubMed ID: 34551281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Promise of Proteomics for the Study of ADP-Ribosylation.
    Daniels CM; Ong SE; Leung AK
    Mol Cell; 2015 Jun; 58(6):911-24. PubMed ID: 26091340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of new tools for detecting poly(ADP-ribose) in vitro and in vivo.
    Challa S; Ryu KW; Whitaker AL; Abshier JC; Camacho CV; Kraus WL
    Elife; 2022 Apr; 11():. PubMed ID: 35476036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical ADP-ribosylation: mono-ADPr-peptides and oligo-ADP-ribose.
    Liu Q; van der Marel GA; Filippov DV
    Org Biomol Chem; 2019 Jun; 17(22):5460-5474. PubMed ID: 31112180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going?
    Hassa PO; Haenni SS; Elser M; Hottiger MO
    Microbiol Mol Biol Rev; 2006 Sep; 70(3):789-829. PubMed ID: 16959969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Family-wide analysis of poly(ADP-ribose) polymerase activity.
    Vyas S; Matic I; Uchima L; Rood J; Zaja R; Hay RT; Ahel I; Chang P
    Nat Commun; 2014 Jul; 5():4426. PubMed ID: 25043379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncovering the Invisible: Mono-ADP-ribosylation Moved into the Spotlight.
    Hopp AK; Hottiger MO
    Cells; 2021 Mar; 10(3):. PubMed ID: 33808662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Players in ADP-ribosylation: Readers and Erasers.
    Verheugd P; Bütepage M; Eckei L; Lüscher B
    Curr Protein Pept Sci; 2016; 17(7):654-667. PubMed ID: 27090904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADP-Ribosylated Peptide Enrichment and Site Identification: The Phosphodiesterase-Based Method.
    Daniels CM; Ong SE; Leung AKL
    Methods Mol Biol; 2017; 1608():79-93. PubMed ID: 28695505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease.
    Prokhorova E; Agnew T; Wondisford AR; Tellier M; Kaminski N; Beijer D; Holder J; Groslambert J; Suskiewicz MJ; Zhu K; Reber JM; Krassnig SC; Palazzo L; Murphy S; Nielsen ML; Mangerich A; Ahel D; Baets J; O'Sullivan RJ; Ahel I
    Mol Cell; 2021 Jun; 81(12):2640-2655.e8. PubMed ID: 34019811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral Macro Domains Reverse Protein ADP-Ribosylation.
    Li C; Debing Y; Jankevicius G; Neyts J; Ahel I; Coutard B; Canard B
    J Virol; 2016 Oct; 90(19):8478-86. PubMed ID: 27440879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ENPP1 processes protein ADP-ribosylation in vitro.
    Palazzo L; Daniels CM; Nettleship JE; Rahman N; McPherson RL; Ong SE; Kato K; Nureki O; Leung AK; Ahel I
    FEBS J; 2016 Sep; 283(18):3371-88. PubMed ID: 27406238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoproteomic approach to characterize protein mono- and poly(ADP-ribosyl)ation sites from cells.
    Daniels CM; Ong SE; Leung AK
    J Proteome Res; 2014 Aug; 13(8):3510-22. PubMed ID: 24920161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleolar-nucleoplasmic shuttling of TARG1 and its control by DNA damage-induced poly-ADP-ribosylation and by nucleolar transcription.
    Bütepage M; Preisinger C; von Kriegsheim A; Scheufen A; Lausberg E; Li J; Kappes F; Feederle R; Ernst S; Eckei L; Krieg S; Müller-Newen G; Rossetti G; Feijs KLH; Verheugd P; Lüscher B
    Sci Rep; 2018 Apr; 8(1):6748. PubMed ID: 29712969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role of intracellular mono-ADP-ribosylation in cancer biology.
    Scarpa ES; Fabrizio G; Di Girolamo M
    FEBS J; 2013 Aug; 280(15):3551-62. PubMed ID: 23590234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.